Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK, Hart LL, Gupta S, Garay CA, Burger BG, Le Bail N, Haller DG
J Clin Oncol. 2003 21 (11): 2059-69

PMID: 12775730 · DOI:10.1200/JCO.2003.11.126

MeSH Terms (19)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Camptothecin Colorectal Neoplasms Disease-Free Survival Female Fluorouracil Humans Irinotecan Leucovorin Male Middle Aged Neoplasm Metastasis Organoplatinum Compounds Oxaliplatin Survival Rate United States

Connections (1)

This publication is referenced by other Labnodes entities: